Saretta Francesca, Mori Francesca, Cardinale Fabio, Liotti Lucia, Franceschini Fabrizio, Crisafulli Giuseppe, Caimmi Silvia, Bottau Paolo, Bernardini Roberto, Caffarelli Carlo
Pediatric Department, AAS2 Bassa Friulana-Isontina, Palmanova-Latisana, Italy; Pediatric Allergy Unit, Department of Medicine, Udine, Italy.
Acta Biomed. 2019 Jan 30;90(3-S):94-107. doi: 10.23750/abm.v90i3-S.8171.
Along with the anamnesis and clinical evaluation, diagnostic tests are one of the mainstream key points in the evaluation and management of drug hypersensitivity reactions (DHR). A wide knowledge gap, both in diagnosis and management of pediatric DHR, must be filled. Only a few published studies evaluated sensitivity and specificity of skin and in vitro tests in children. However, selected case series show that diagnostic work-up for adults could be useful, with some limitations, in pediatric age. Indeed, despite improvement in in vivo and in vitro diagnosis, drug provocation test remains the gold standard in pediatric age, too. Unmet needs in children include multi-centric studies on incidence of DHR, utility and feasibility of in vivo and in vitro diagnostic tests and specifically dedicated guidelines for the diagnosis and management of DHR in children.
除了病史采集和临床评估外,诊断测试是药物过敏反应(DHR)评估和管理的主流关键点之一。儿科DHR的诊断和管理方面存在巨大的知识空白,必须加以填补。仅有少数已发表的研究评估了儿童皮肤试验和体外试验的敏感性和特异性。然而,部分病例系列研究表明,针对成人的诊断检查在儿科虽有一定局限性,但仍可能有用。事实上,尽管体内和体外诊断有所改进,但药物激发试验在儿科仍是金标准。儿童未满足的需求包括关于DHR发病率的多中心研究、体内和体外诊断测试的效用和可行性,以及专门针对儿童DHR诊断和管理的指南。